COVID-19 and diabetes: The IRCM diabetes clinic in action

COVID-19 and diabetes: The IRCM diabetes clinic in action

If the growing COVID-19 pandemic brings uncertainty to the entire world population, the concern it creates for those with pre-existing health conditions is even greater. This is particularly the case for people living with type 1 diabetes.

Are people with type 1 diabetes more at risk from COVID-19? Should we expect insulin shortages in pharmacies? What to do if you have planned medical visits or blood tests? Or what medications should be avoided if you have COVID-19?

To help answer these questions, the IRCM Diabetes Clinic directed by Dr. Rémi Rabasa-Lhoret, and partners, have put together a series of resources to reassure patients. Dr. Rabasa-Lhoret was live on Facebook on March 25th to answer 7 of the most asked questions on the subject, and address concerns voiced by the public. 

Watch the video:

Other resources offered by The Better Project:

Insulin and Diabetes Supplies: No Shortage in Sight
Coronavirus and COVID-19: Recommendations About NSAIDs (Ibuprofen, Aspirin) and Cortisone (Prednisone, Cortef)
Clarification on a Few Protective Measures Against the Novel Coronavirus (COVID-19)
Antihypertensive drugs and coronavirus disease (COVID-19)
Preventive measures against coronavirus disease (COVID-19) and type 1 diabetes

Stay tuned for more news

In the media:

On the Entre-Nous program on Rogers.TV, Dr. Rabasa-Lhoret answered Claude Andréa Bonny’s questions about diabetes, new technologies and COVID-19. Interview in French only

Back to news list


events and more


IRCM Foundation

Be part of the

Support health research